marketnetra
Sign inStart free

Wockhardt Limited

NSE: WOCKPHARMAHealthcare

Wockhardt Limited Share Price & Analysis

₹1913.40+1.52%Updated 28 Oct 2026, 03:30 pm IST
LTP
₹1913.40+1.52%
Open
₹1879.20
High
₹1933.00
Low
₹1864.30
Close
₹1913.40
52W High
₹2422.30
52W Low
₹1086.70
Volume
491K
Lot Size
1
Sector
Healthcare
Market Cap
₹29K Cr
Face Value
₹5
Large CapNIFTY 500SMALLCAP 100Nifty Smallcap 250

Price Chart

Candle
Range

Fundamentals

P/E
73.40
Sector P/E
50.20
P/B
6.98
EPS
₹13.13
ROE
6.11%
ROCE
7.55%
D/E Ratio
0.42
Div Yield
0.00%
Book Value
₹304.00

Strengths

  • Low debt relative to equity (D/E 0.4x)

Concerns

    Peer Comparison

    CompanyCMPMkt CapP/EP/BROE %ROCE %D/E
    SUNPHARMA
    Sun Pharmaceutical Industries Limited
    ₹1,758
    		₹4.2L Cr33.25.051620.50.07
    DIVISLAB
    Divi's Laboratories Limited
    ₹9,559
    		₹2.4L Cr79.815.1516.5220.01
    TORNTPHARM
    Torrent Pharmaceuticals Limited
    ₹4,557
    		₹1.7L Cr79.39.4327.415.20.77
    ZYDUSLIFE
    Zydus Lifesciences Limited
    ₹1,176
    		₹1.1L Cr23.14.3721.221.10.38
    APOLLOHOSP
    Apollo Hospitals Enterprise Limited
    ₹8,137
    		₹1.1L Cr52.812.3521.217.40.88
    CIPLA
    Cipla Limited
    ₹1,366
    		₹1.1L Cr30.23.2111.615.50.01
    LAURUSLABS
    Laurus Labs Limited
    ₹2,182
    		₹1.1L Cr97.422.2218.317.80.46

    Showing 7 peers in the same sector · Sorted by market cap

    Shareholding Pattern

    WOCKPHARMA · as of Mar 2026

    Promoters49.09%
    FII6.82%0.28pp
    DII10.58%0.76pp
    Public33.50%1.04pp
    Govt0.02%
    CategoryDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
    Promoters54.93%51.60%51.99%51.99%49.09%49.09%
    FII4.18%5.49%5.94%6.70%6.54%6.82%
    DII0.30%4.82%4.45%5.08%9.82%10.58%
    Public40.59%38.06%37.62%36.21%34.54%33.50%
    Govt—0.01%0.01%0.02%0.02%0.02%

    Corporate Events

    To consider and approve the financial results for the period ended September 30, 2026

    Results1 Nov 2026

    Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company will be held on Monday, 10th August, 2026, inter-alia, to consider and

    Results9 Aug 2026

    Annual General Meeting

    AGM20 Jun 2024

    Annual General Meeting

    AGM6 Aug 2023

    Latest News

    All news

    Wockhardt announces board meeting outcome

    *Wockhardt announces board meeting outcome.* The company disclosed the outcome of its recent board meeting as per SEBI listing norms. No major financial figures or strategic decisions were revealed in the update. This is a routine regulatory disclosure. 📊 *STOCKS:* $WOCKPHARMA | 🏢 *SECTOR:* Pharma | #LOWIMPACT #BoardMeeting

    NSE Filing10 Aug
    High Impact

    Wockhardt allots 20,000 shares under ESOP scheme

    *Wockhardt allots 20,000 shares under ESOP scheme.* The company allotted **20,000 equity shares** of ₹5 face value each on **27th October 2026**, following the exercise of stock options under its ESOP scheme. The allotment was approved by the Share Allotment Committee. This is a routine employee compensation activity with minimal market impact. 📊 *STOCKS:* $WOCKPHARMA | 🏢 *SECTOR:* Pharma | #LOWIMPACT #ESOP

    NSE Filing1d ago
    Low Impact

    Wockhardt announces 27th AGM via newspaper notice

    *Wockhardt announces 27th AGM via newspaper notice.* The company published public notices in Lokmat and Business Standard on **July 3, 2026**, for its upcoming AGM. This is part of compliance under SEBI Listing Regulations. No financial or operational updates were disclosed. 📊 *STOCKS:* WOCKPHARMA | 🏢 *SECTOR:* Pharma | #LOWIMPACT #AGM

    NSE Filing3 Jul
    Low Impact

    Wockhardt shares may react to investor meet updates

    *Wockhardt shares may react to investor meet updates.* The company shared the transcript of its recent Analyst/Institutional Investor Meet pursuant to SEBI listing regulations. No major financial announcements or strategic shifts were disclosed. **No material triggers** for immediate trading action noted. 📊 *STOCKS:* WOCKPHARMA | 🏢 *SECTOR:* Pharma | #LOWIMPACT #InvestorMeet

    NSE Filing11 Jun
    Low Impact

    Financials

    Quarterly Results

    MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
    Revenue
    ₹965 Cr
    8.7%
    ₹888 Cr
    13.6%
    ₹782 Cr
    6.0%
    ₹738 Cr
    0.7%
    ₹743 Cr
    3.1%
    ₹721 Cr
    10.9%
    ₹809 Cr
    9.5%
    ₹739 Cr
    Op. Profit
    ₹225 Cr
    27.1%
    ₹177 Cr
    0.6%
    ₹178 Cr
    147.2%
    ₹72 Cr
    12.5%
    ₹64 Cr
    50.0%
    ₹128 Cr
    16.4%
    ₹110 Cr
    20.9%
    ₹91 Cr
    OPM
    23.0%
    15.0%
    20.0%
    13.0%
    23.0%
    130.0%
    10.0%
    11.1%
    9.0%
    50.0%
    18.0%
    28.6%
    14.0%
    16.7%
    12.0%
    Net Profit
    ₹164 Cr
    168.9%
    ₹61 Cr
    25.6%
    ₹82 Cr
    175.9%
    ₹-108 Cr
    140.0%
    ₹-45 Cr
    325.0%
    ₹20 Cr
    225.0%
    ₹-16 Cr
    0.0%
    ₹-16 Cr
    EPS (₹)
    10.22
    181.5%
    3.63
    24.4%
    4.8
    186.6%
    -5.54
    259.7%
    -1.54
    279.1%
    0.86
    160.1%
    -1.43
    57.1%
    -0.91

    Values in ₹ Cr · Source: Screener.in

    Annual Profit & Loss

    MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
    Revenue
    ₹3.4K Cr
    12.0%
    ₹3.0K Cr
    7.6%
    ₹2.8K Cr
    5.5%
    ₹2.7K Cr
    17.9%
    ₹3.2K Cr
    19.3%
    ₹2.7K Cr
    4.8%
    ₹2.8K Cr
    20.2%
    ₹3.6K Cr
    9.4%
    ₹3.9K Cr
    1.9%
    ₹4.0K Cr
    Expenses
    ₹2.7K Cr
    3.9%
    ₹2.6K Cr
    3.3%
    ₹2.7K Cr
    6.2%
    ₹2.5K Cr
    13.1%
    ₹2.9K Cr
    5.8%
    ₹2.8K Cr
    1.7%
    ₹2.7K Cr
    24.4%
    ₹3.6K Cr
    8.4%
    ₹3.9K Cr
    1.7%
    ₹4.0K Cr
    Op. Profit
    ₹652 Cr
    65.9%
    ₹393 Cr
    331.9%
    ₹91 Cr
    10.8%
    ₹102 Cr
    65.8%
    ₹298 Cr
    573.0%
    ₹-63 Cr
    152.9%
    ₹119 Cr
    413.2%
    ₹-38 Cr
    2000.0%
    ₹2 Cr
    84.6%
    ₹13 Cr
    OPM
    19.0%
    46.2%
    13.0%
    306.3%
    3.2%
    17.9%
    3.9%
    56.7%
    9.0%
    491.3%
    -2.3%
    154.8%
    4.2%
    481.8%
    -1.1%
    1200.0%
    0.1%
    66.7%
    0.3%
    Other Income
    ₹26 Cr
    58.1%
    ₹62 Cr
    264.7%
    ₹17 Cr
    109.8%
    ₹-173 Cr
    6.1%
    ₹-163 Cr
    116.7%
    ₹975 Cr
    633.1%
    ₹133 Cr
    14.7%
    ₹116 Cr
    148.7%
    ₹-238 Cr
    308.8%
    ₹114 Cr
    Interest
    ₹213 Cr
    16.1%
    ₹254 Cr
    16.7%
    ₹305 Cr
    1.0%
    ₹302 Cr
    1.0%
    ₹299 Cr
    20.1%
    ₹249 Cr
    9.8%
    ₹276 Cr
    4.2%
    ₹265 Cr
    3.9%
    ₹255 Cr
    13.3%
    ₹225 Cr
    Depreciation
    ₹227 Cr
    4.6%
    ₹217 Cr
    2.7%
    ₹223 Cr
    11.2%
    ₹251 Cr
    1.6%
    ₹247 Cr
    0.4%
    ₹246 Cr
    9.8%
    ₹224 Cr
    36.6%
    ₹164 Cr
    9.3%
    ₹150 Cr
    0.7%
    ₹149 Cr
    PBT
    ₹238 Cr
    1587.5%
    ₹-16 Cr
    96.2%
    ₹-420 Cr
    32.7%
    ₹-624 Cr
    51.8%
    ₹-411 Cr
    198.6%
    ₹417 Cr
    268.8%
    ₹-247 Cr
    29.6%
    ₹-351 Cr
    45.2%
    ₹-641 Cr
    159.5%
    ₹-247 Cr
    Tax %
    16.0%
    93.8%
    256.0%
    2033.3%
    12.0%
    0.0%
    100.0%
    -32.0%
    50.8%
    -65.0%
    20.7%
    -82.0%
    115.8%
    -38.0%
    1050.0%
    4.0%
    144.4%
    -9.0%
    Net Profit
    ₹199 Cr
    449.1%
    ₹-57 Cr
    87.9%
    ₹-472 Cr
    24.0%
    ₹-621 Cr
    122.6%
    ₹-279 Cr
    140.6%
    ₹688 Cr
    1700.0%
    ₹-43 Cr
    80.2%
    ₹-217 Cr
    67.5%
    ₹-667 Cr
    195.1%
    ₹-226 Cr
    EPS (₹)
    13.11
    553.6%
    -2.89
    90.4%
    -30.18
    22.2%
    -38.8
    129.0%
    -16.94
    135.6%
    47.64
    1090.4%
    -4.81
    64.4%
    -13.52
    68.0%
    -42.3
    210.6%
    -13.62
    Div Payout
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%
    100.0%
    -56.0%

    Values in ₹ Cr · Source: Screener.in

    Balance Sheet

    ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
    Liabilities
    Equity Capital
    ₹81 Cr
    0.0%
    ₹81 Cr
    5.2%
    ₹77 Cr
    6.9%
    ₹72 Cr
    0.0%
    ₹72 Cr
    30.9%
    ₹55 Cr
    0.0%
    ₹55 Cr
    0.0%
    ₹55 Cr
    0.0%
    ₹55 Cr
    0.0%
    ₹55 Cr
    Reserves
    ₹4.9K Cr
    13.7%
    ₹4.3K Cr
    30.2%
    ₹3.3K Cr
    0.0%
    ₹3.3K Cr
    13.1%
    ₹3.8K Cr
    13.7%
    ₹3.3K Cr
    26.9%
    ₹2.6K Cr
    0.1%
    ₹2.6K Cr
    6.4%
    ₹2.8K Cr
    14.8%
    ₹3.3K Cr
    Borrowings
    ₹2.2K Cr
    10.5%
    ₹2.0K Cr
    14.2%
    ₹2.4K Cr
    7.9%
    ₹2.2K Cr
    0.6%
    ₹2.2K Cr
    17.8%
    ₹2.7K Cr
    25.3%
    ₹3.6K Cr
    6.1%
    ₹3.4K Cr
    10.0%
    ₹3.7K Cr
    9.9%
    ₹4.2K Cr
    Other Liabilities
    ₹1.4K Cr
    18.6%
    ₹1.7K Cr
    9.1%
    ₹1.9K Cr
    10.1%
    ₹2.1K Cr
    2.5%
    ₹2.2K Cr
    27.8%
    ₹1.7K Cr
    10.5%
    ₹1.9K Cr
    7.4%
    ₹1.8K Cr
    15.4%
    ₹1.5K Cr
    2.8%
    ₹1.5K Cr
    Total Liabilities
    ₹8.6K Cr
    5.9%
    ₹8.1K Cr
    6.4%
    ₹7.6K Cr
    0.5%
    ₹7.7K Cr
    6.9%
    ₹8.2K Cr
    6.1%
    ₹7.7K Cr
    4.9%
    ₹8.1K Cr
    4.3%
    ₹7.8K Cr
    3.9%
    ₹8.1K Cr
    9.5%
    ₹9.0K Cr
    Assets
    Fixed Assets
    ₹2.8K Cr
    2.0%
    ₹2.7K Cr
    5.0%
    ₹2.9K Cr
    5.3%
    ₹3.0K Cr
    12.1%
    ₹3.5K Cr
    3.6%
    ₹3.3K Cr
    4.5%
    ₹3.5K Cr
    14.5%
    ₹3.1K Cr
    5.9%
    ₹2.9K Cr
    4.1%
    ₹2.8K Cr
    CWIP
    ₹2.4K Cr
    17.0%
    ₹2.0K Cr
    18.1%
    ₹1.7K Cr
    11.9%
    ₹1.5K Cr
    14.7%
    ₹1.3K Cr
    2.7%
    ₹1.4K Cr
    13.0%
    ₹1.6K Cr
    9.7%
    ₹1.4K Cr
    0.8%
    ₹1.4K Cr
    15.2%
    ₹1.2K Cr
    Investments
    ₹412 Cr
    2.4%
    ₹422 Cr
    ₹0 Cr
    ₹0 Cr
    ₹0 Cr
    ₹0 Cr
    ₹0 Cr
    ₹0 Cr
    100.0%
    ₹214 Cr
    62.0%
    ₹563 Cr
    Other Assets
    ₹3.0K Cr
    3.0%
    ₹2.9K Cr
    3.4%
    ₹3.0K Cr
    1.9%
    ₹3.1K Cr
    10.0%
    ₹3.4K Cr
    12.8%
    ₹3.0K Cr
    1.2%
    ₹3.1K Cr
    7.5%
    ₹3.3K Cr
    7.9%
    ₹3.6K Cr
    18.4%
    ₹4.4K Cr
    Total Assets
    ₹8.6K Cr
    5.9%
    ₹8.1K Cr
    6.4%
    ₹7.6K Cr
    0.5%
    ₹7.7K Cr
    6.9%
    ₹8.2K Cr
    6.1%
    ₹7.7K Cr
    4.9%
    ₹8.1K Cr
    4.3%
    ₹7.8K Cr
    3.9%
    ₹8.1K Cr
    9.5%
    ₹9.0K Cr

    Values in ₹ Cr · Source: Screener.in

    Cash Flow Statement

    ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
    Operating CF
    ₹390 Cr
    1872.7%
    ₹-22 Cr
    110.0%
    ₹219 Cr
    43.1%
    ₹153 Cr
    63.0%
    ₹413 Cr
    243.9%
    ₹-287 Cr
    144.2%
    ₹649 Cr
    254.6%
    ₹183 Cr
    169.1%
    ₹68 Cr
    125.3%
    ₹-269 Cr
    Investing CF
    ₹-231 Cr
    70.4%
    ₹-780 Cr
    465.2%
    ₹-138 Cr
    16.9%
    ₹-118 Cr
    42.2%
    ₹-204 Cr
    113.9%
    ₹1.5K Cr
    1100.7%
    ₹-147 Cr
    258.1%
    ₹93 Cr
    85.4%
    ₹635 Cr
    192.8%
    ₹-684 Cr
    Financing CF
    ₹-54 Cr
    113.2%
    ₹409 Cr
    22.5%
    ₹334 Cr
    206.0%
    ₹-315 Cr
    343.7%
    ₹-71 Cr
    93.9%
    ₹-1.2K Cr
    72.2%
    ₹-680 Cr
    12.4%
    ₹-776 Cr
    0.9%
    ₹-769 Cr
    161.3%
    ₹1.3K Cr
    Net Cash Flow
    ₹105 Cr
    126.7%
    ₹-393 Cr
    194.7%
    ₹415 Cr
    248.2%
    ₹-280 Cr
    302.9%
    ₹138 Cr
    961.5%
    ₹13 Cr
    107.3%
    ₹-178 Cr
    64.4%
    ₹-500 Cr
    657.6%
    ₹-66 Cr
    121.9%
    ₹301 Cr
    Free Cash Flow
    ₹76 Cr
    120.2%
    ₹-377 Cr
    646.4%
    ₹69 Cr
    200.0%
    ₹23 Cr
    88.6%
    ₹202 Cr
    144.7%
    ₹-452 Cr
    193.0%
    ₹486 Cr
    282.7%
    ₹127 Cr
    153.4%
    ₹-238 Cr
    64.9%
    ₹-678 Cr

    Values in ₹ Cr · Source: Screener.in

    Key Ratios History

    MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
    Debtor Days
    64d
    20.0%
    80d
    1.2%
    81d
    26.4%
    110d
    5.8%
    104d
    16.1%
    124d
    22.0%
    159d
    22.3%
    130d
    46.1%
    89d
    5.3%
    94d
    Inventory Days
    286d
    22.2%
    234d
    16.4%
    201d
    6.9%
    216d
    2.7%
    222d
    13.3%
    256d
    22.5%
    209d
    14.2%
    183d
    5.2%
    174d
    28.4%
    243d
    Days Payable
    182d
    4.7%
    191d
    20.4%
    240d
    15.8%
    285d
    7.5%
    265d
    18.8%
    223d
    18.0%
    272d
    45.5%
    187d
    53.3%
    122d
    4.3%
    117d
    Cash Conv. Cycle
    168d
    36.6%
    123d
    200.0%
    41d
    0.0%
    41d
    31.7%
    60d
    61.8%
    157d
    61.9%
    97d
    23.0%
    126d
    10.6%
    141d
    35.9%
    220d
    Working Capital Days
    35d
    252.2%
    -23d
    85.9%
    -163d
    12.4%
    -186d
    60.3%
    -116d
    12.8%
    -133d
    22.2%
    -171d
    235.3%
    -51d
    8.9%
    -56d
    255.6%
    36d
    ROCE
    8.0%
    100.0%
    4.0%
    500.0%
    -1.0%
    0.0%
    100.0%
    1.0%
    133.3%
    -3.0%
    200.0%
    -1.0%
    0.0%
    -1.0%
    0.0%
    -1.0%
    0.0%
    -1.0%

    Source: Screener.in · Lower days = better efficiency

    Related Analysis

    Same Sector

    ALKEMAlkem Laboratories LimitedNeutralAPOLLOHOSPApollo Hospitals Enterprise LimitedNeutralAUROPHARMAAurobindo Pharma LimitedNeutralBIOCONBiocon LimitedNeutralCIPLACipla LimitedNeutral

    Frequently Asked Questions

    What is Wockhardt Limited share price today?
    Wockhardt Limited (WOCKPHARMA) is currently trading at ₹1,913.4 on NSE, up 1.52% as of the last market session. Prices update daily after market close on MarketNetra.
    Is Wockhardt Limited available in F&O (Futures & Options)?
    Yes, Wockhardt Limited (WOCKPHARMA) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
    What is Wockhardt Limited 52-week high and low?
    Wockhardt Limited's 52-week high is ₹2,422.3 and the 52-week low is ₹1,086.7. The current price of ₹1,913.4 is 21.0% below the 52W high.
    What is Wockhardt Limited P/E ratio?
    Wockhardt Limited's current P/E ratio is 73.4. This indicates the market is paying ₹73.4 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
    How to trade Wockhardt Limited options?
    Wockhardt Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade WOCKPHARMA options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.